tradingkey.logo

Masimo Corp

MASI
139.150USD
+3.820+2.82%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
7.39BMarktkapitalisierung
VerlustKGV TTM

Masimo Corp

139.150
+3.820+2.82%

mehr Informationen über Masimo Corp Unternehmen

Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.

Masimo Corp Informationen

BörsenkürzelMASI
Name des UnternehmensMasimo Corp
IPO-datumAug 08, 2007
CEOSzyman (Catherine M)
Anzahl der mitarbeiter3600
WertpapierartOrdinary Share
GeschäftsjahresendeAug 08
Addresse52 Discovery
StadtIRVINE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92618
Telefon19492977000
Websitehttps://www.masimo.com/
BörsenkürzelMASI
IPO-datumAug 08, 2007
CEOSzyman (Catherine M)

Führungskräfte von Masimo Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
15.54K
+6922.00%
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Director
Independent Director
--
--
Ms. Wendy E. Lane
Ms. Wendy E. Lane
Independent Director
Independent Director
--
--
Ms. Catherine M. (Katie) Szyman
Ms. Catherine M. (Katie) Szyman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Tim Benner
Mr. Tim Benner
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
15.54K
+6922.00%
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2023
FY2022
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
1.13B
53.84%
Europe, Middle East and Africa
595.60M
28.44%
Asia and Australia
303.50M
14.49%
North and South America (excluding the U.S.)
67.70M
3.23%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Nov 30
Aktualisiert: Sun, Nov 30
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
12.88%
Politan Capital Management, L.P.
8.54%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
8.02%
BlackRock Investment Management (UK) Ltd.
5.61%
Andere
56.87%
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
12.88%
Politan Capital Management, L.P.
8.54%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
8.02%
BlackRock Investment Management (UK) Ltd.
5.61%
Andere
56.87%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
54.68%
Investment Advisor/Hedge Fund
32.53%
Hedge Fund
13.45%
Individual Investor
5.75%
Research Firm
3.52%
Pension Fund
1.04%
Bank and Trust
0.39%
Venture Capital
0.18%
Sovereign Wealth Fund
0.14%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
827
56.90M
105.94%
-6.07M
2025Q3
847
60.04M
111.77%
-4.36M
2025Q2
937
59.97M
110.39%
-7.53M
2025Q1
981
59.62M
109.96%
-8.22M
2024Q4
950
56.99M
105.70%
-7.11M
2024Q3
945
55.24M
103.11%
-8.43M
2024Q2
962
54.27M
102.01%
-12.67M
2024Q1
1002
56.30M
106.05%
-9.64M
2023Q4
1090
55.26M
104.56%
-6.33M
2023Q3
1093
52.14M
98.67%
-6.57M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fidelity Management & Research Company LLC
6.92M
12.88%
-25.87K
-0.37%
Sep 30, 2025
Politan Capital Management, L.P.
4.59M
8.54%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
4.80M
8.93%
+171.32K
+3.70%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.31M
8.02%
+70.24K
+1.66%
Sep 30, 2025
BlackRock Investment Management (UK) Ltd.
3.02M
5.61%
-61.18K
-1.99%
Sep 30, 2025
Kiani (Joe E)
2.87M
5.34%
-245.80K
-7.90%
Sep 30, 2025
MFS Investment Management
2.61M
4.87%
+149.74K
+6.07%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
2.13M
3.96%
-373.38K
-14.93%
Sep 30, 2025
Capital Research Global Investors
1.85M
3.45%
-1.54K
-0.08%
Sep 30, 2025
BlackRock Financial Management, Inc.
1.61M
3%
-224.33K
-12.22%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Harbor Health Care ETF
4.85%
iShares US Select Equity Active ETF
3.53%
Global X HealthTech ETF
3.3%
First Trust Nasdaq Lux Digi Health Solutions ETF
2.63%
First Trust Indxx Medical Devices ETF
1.95%
State Street SPDR S&P Health Care Equipment ETF
1.72%
Langar Global HealthTech ETF
1.72%
ROBO Global Healthcare Technology & Innovation ETF
1.27%
Tema Heart & Health ETF
1.24%
Invesco S&P MidCap 400 Pure Growth ETF
1.18%
Mehr Anzeigen
Harbor Health Care ETF
Anteil4.85%
iShares US Select Equity Active ETF
Anteil3.53%
Global X HealthTech ETF
Anteil3.3%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil2.63%
First Trust Indxx Medical Devices ETF
Anteil1.95%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.72%
Langar Global HealthTech ETF
Anteil1.72%
ROBO Global Healthcare Technology & Innovation ETF
Anteil1.27%
Tema Heart & Health ETF
Anteil1.24%
Invesco S&P MidCap 400 Pure Growth ETF
Anteil1.18%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI